Singapore markets closed
Straits Times Index
3,199.01 +25.19 (+0.79%) S&P 500
4,515.40 +28.94 (+0.65%) Dow
35,458.40 +199.79 (+0.57%) Nasdaq
15,105.65 +83.84 (+0.56%) BTC-USD
62,704.49 +709.24 (+1.14%) CMC Crypto 200
1,458.82 -4.54 (-0.31%)
Regeneron Pharmaceuticals, Inc. (REGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
554.87+11.39 (+2.10%)
As of 11:17AM EDT. Market open.
Currency in USD
Valuation measures
| Market cap (intra-day) 5 | 58.13B |
| Enterprise value 3 | 56.91B |
| Trailing P/E | 9.78 |
| Forward P/E 1 | 11.06 |
| PEG Ratio (5 yr expected) 1 | 0.96 |
| Price/sales (ttm) | 4.92 |
| Price/book (mrq) | 3.84 |
| Enterprise value/revenue 3 | 4.60 |
| Enterprise value/EBITDA 7 | 7.53 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.21 |
| 52-week change 3 | -5.75% |
| S&P500 52-week change 3 | 30.30% |
| 52-week high 3 | 686.62 |
| 52-week low 3 | 441.00 |
| 50-day moving average 3 | 615.29 |
| 200-day moving average 3 | 563.70 |
Share statistics
| Avg vol (3-month) 3 | 767.35k |
| Avg vol (10-day) 3 | 805.33k |
| Shares outstanding 5 | 105.11M |
| Implied shares outstanding 6 | 106.95M |
| Float 8 | 99.26M |
| % held by insiders 1 | 2.75% |
| % held by institutions 1 | 88.98% |
| Shares short (29 Sep 2021) 4 | 1.8M |
| Short ratio (29 Sep 2021) 4 | 2.53 |
| Short % of float (29 Sep 2021) 4 | 2.02% |
| Short % of shares outstanding (29 Sep 2021) 4 | 1.68% |
| Shares short (prior month 30 Aug 2021) 4 | 1.36M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | N/A |
| Trailing annual dividend yield 3 | N/A |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2020 |
| Most-recent quarter (mrq) | 29 Jun 2021 |
Profitability
| Profit margin | 50.88% |
| Operating margin (ttm) | 52.46% |
Management effectiveness
| Return on assets (ttm) | 22.27% |
| Return on equity (ttm) | 51.32% |
Income statement
| Revenue (ttm) | 12.2B |
| Revenue per share (ttm) | 115.78 |
| Quarterly revenue growth (yoy) | 163.20% |
| Gross profit (ttm) | 4.46B |
| EBITDA | 6.66B |
| Net income avi to common (ttm) | 6.21B |
| Diluted EPS (ttm) | 55.38 |
| Quarterly earnings growth (yoy) | 245.40% |
Balance sheet
| Total cash (mrq) | 3.91B |
| Total cash per share (mrq) | 37.62 |
| Total debt (mrq) | 2.7B |
| Total debt/equity (mrq) | 17.83 |
| Current ratio (mrq) | 3.57 |
| Book value per share (mrq) | 145.83 |
Cash flow statement
| Operating cash flow (ttm) | 2.27B |
| Levered free cash flow (ttm) | 236.12M |
© 2021 Verizon Media. All rights reserved.
